Stock listing
Central Pharmaceutical Jsc No. 3
Selected listing: DP3 · HNX · VND · VN
Central Pharmaceutical Jsc No. 3 (HNX:DP3), Health Technology. Latest release Apr 20, 2026: Central Pharmaceutical Joint Stock Company No3: Q1 2026 saw robust…
- Ticker
- HNX:DP3
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- HNX
- Currency
- VND
About Central Pharmaceutical Jsc No. 3
The company focuses on the pharmaceutical sector, contributing to healthcare solutions in Vietnam. Investors can find more information about its operations and performance on its public company page.
Latest news from Central Pharmaceutical Jsc No. 3
Central Pharmaceutical Joint Stock Company No3: Q1 2026 saw robust revenue and profit growth, higher margins, and improved cash flow
April 20, 2026
Central Pharmaceutical Joint Stock Company No3: Net profit after tax surged 26.8% to VND 153.6 billion in 2025, with strong revenue growth
January 20, 2026
Central Pharmaceutical Joint Stock Company No3: Net profit and revenue rose year-over-year, but liquidity declined due to investments and dividends
October 20, 2025
Central Pharmaceutical Joint Stock Company No3: Q2/2025 net profit increased to VND 32.10 billion as margins and cash flow improved
July 18, 2025
Central Pharmaceutical Joint Stock Company No3: Net profit grew 8.3% year-over-year in Q1 2025, with improved cash flow and margins
May 19, 2025
Research Central Pharmaceutical Jsc No. 3
Central Pharmaceutical Jsc No. 3 company profile
View the public company page for Central Pharmaceutical Jsc No. 3 on 6ix.
Central Pharmaceutical Jsc No. 3 news
Read company news and market updates connected to Central Pharmaceutical Jsc No. 3.
Central Pharmaceutical Jsc No. 3 investor events
Find investor webinars, events, and replay context for Central Pharmaceutical Jsc No. 3.